Privi Speciality Chemicals Ltd (PRIVISCL) Q1 FY27 Results Analysis: PAT Surges 36%, Margin Misses Guidance
Privi Speciality Chemicals Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 666.22 Cr (+19.22% YoY) and PAT growth of +35.97% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | July 30, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Revenue (Q1) | Rs. 666.22 Cr (+19.22% YoY) |
| PAT (Q1) | Rs. 84.21 Cr (+35.97% YoY) |
| EBITDA margin | 22.86% (-77 bps YoY) |
| EPS (Q1) | Rs. 21.56 (+36.03% YoY) |
| Market cap | Rs. 13,957.10 Cr |
| CMP | Rs. 3,573.00 |
Quarter Snapshot
Privi Speciality Chemicals reported 19.22% YoY revenue growth to Rs.666.22 Cr, with PAT attributable to owners surging 35.97% YoY. However, consolidated EBITDA margin of 22.86% missed the guided 24-26% band due to raw material cost pressure. The subsidiary drag virtually disappeared, confirming the PRIGIV JV's profitability milestone, while forex gains boosted other income.
Key Investment Insights
Key Positives
- Revenue grew 19.22% YoY to Rs.666.22 Cr.
- PAT attributable to owners grew 35.97% YoY to Rs.84.21 Cr.
- Subsidiary drag narrowed from Rs.6.76 Cr to Rs.0.06 Cr, with PRIGIV turning profitable.
- Finance costs declined 29.23% YoY to Rs.16.74 Cr.
- Standalone EBITDA margin of 24.24% remained within the 24-26% guided band.
Risk Factors
- Consolidated EBITDA margin of 22.86% fell below the guided 24-26% band.
- Raw material cost pressure: cost of materials as % of revenue rose 485 bps YoY to 59.57%.
- Revenue declined 7.66% sequentially, though Q1 is seasonally weak.
- Elevated other income from forex gains is volatile and may not be sustainable.
Ask about this
Ask Cofacto a question about this result. Answers cite filings and company data.
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.